Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,566
Closed -$212K 434
2024
Q1
$212K Buy
5,566
+979
+21% +$58.9K 0.01% 412
2023
Q4
$357K Sell
4,587
-1,076
-19% -$66.6K 0.03% 330
2023
Q3
$325K Hold
5,663
0.03% 329
2023
Q2
$293K Sell
5,663
-735
-11% -$39.5K 0.02% 342
2023
Q1
$430K Sell
6,398
-496
-7% -$39K 0.03% 284
2022
Q4
$527K Buy
6,894
+415
+6% +$30.9K 0.04% 248
2022
Q3
$522K Sell
6,479
-229
-3% -$21.8K 0.04% 244
2022
Q2
$592K Buy
6,708
+2,704
+68% +$283K 0.04% 232
2022
Q1
$533K Buy
4,004
+2,576
+180% +$324K 0.03% 244
2021
Q4
$240K Sell
1,428
-492
-26% -$76.2K 0.01% 344
2021
Q3
$261K Hold
1,920
0.02% 323
2021
Q2
$218K Buy
+1,920
New +$186K 0.01% 346

Other funds holding DAVA

Equitable Trust's DAVA Position: Q2 2024 in Review

Equitable Trust sold out of Endava (DAVA) in Q2 2024, closing a stake of 5,566 shares — an estimated $212K sold.

Equitable Trust first reported a position in DAVA in Q2 2021 and held it in 12 quarters. The position peaked at $592K in Q2 2022. 182 funds tracked by Wall St. Rank hold DAVA as of Q2 2024.

  • Equitable Trust reported no remaining Endava position as of Q2 2024 after selling out during the quarter.
  • Equitable Trust sold 5,566 Endava shares in Q2 2024, an estimated $212K.
  • Equitable Trust first reported a position in Endava in Q2 2021 and held it in 12 quarters.
  • Equitable Trust's Endava position peaked at $592K in Q2 2022.
  • 182 funds tracked by Wall St. Rank held Endava as of Q2 2024.

Based on Equitable Trust's 13F filing for Q2 2024, filed 31 Jul 2024.